Fulminant viral myocarditis treated by interferon-beta in a child
The fulminant viral myocarditis is associated to a high risk of mortality and heart transplantation in children. Anti-inflammatories and intravenous gamma globulin are used in the majority of studies but the outcome is not always favorable. In this case, we suggest an important role for antiviral therapy in children's fulminant myocarditis.
Source: Progress in Pediatric Cardiology - Category: Cardiology Authors: Nabil Tahhan, Rose Fesseau, Lionel Berthomieu, Khaled Hadeed, Fabio Cuttone, Yves Dulac Source Type: research
More News: Antiviral Therapy | Cardiology | Children | Heart | Heart Transplant | Myocarditis | Pediatrics | Study | Transplants